|
|
| MRD / Regn No. |
: 20220000922 |
Date |
: 10/06/2026 |
| Patient Name |
: Revathi Rajavel |
Age & Gender |
: 38 Yrs. / Female |
| Contact No. |
: 9677118526 |
UHID |
: |
| Ht / Wt / BMI |
: 168.4 / 84.9 / 29.94 |
BP S / BP D |
: 130 / 80 |
| Allergies |
: NKA |
Referred By |
: |
| |
|
| Problem
List |
: |
VITAMIN D DEFICIENCY (08/Nov/2023) | DYSLIPIDEMIA (01/Jan/2025) | |
|
Subjective |
: |
NO NEW COMPLAINTS,FATIGUE |
|
Objective |
: |
NO TREMORS,DIFFUSE THYROMEGALY |
|
Analysis |
: |
XANTHALESMA,DYSLIPIDEMIA,VITAMIN D DEFICIENCY,THYROTOXICOSIS IN REMISSION,CAC 74 WITH INCREASED HSCRP,NO DECREASE IN LDL |
|
Plan |
: |
CONTINUE CRESTOR 20 MG,ADD SNRI,SEE ME IN 1 WEEK |
|
| Salient Investigations |
: |
RANDOM BLOOD SUGAR: 90 mg/dL | HEMOGLOBIN: 12.6 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 86 fL | PLATELETS: 342 thou cells/ ul | WBC WHITE BLOOD CELLS: 916 K/uL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 5.3 % | HDL HIGH DENSITY LIPOPROTEIN: 43 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 98 mg/dL | TGL TRIGLYCERIDE: 69 mg/dL | TOTAL CHOLESTEROL: 147 mg/dl | ALBUMIN (SERUM): 4.2 g/dL | ALKALINE PHOSPHOTASE: 66 IU/L | DIRECT BILIRUBIN: 0.2 mg/dl | SGOT (AST): 18 U/L | SGPT (ALT): 17 IU/L | TOTAL BILIRUBIN: 0.5 mg/dL | RANDOM BLOOD SUGAR: 90 mg/dL | HEMOGLOBIN: 12.6 g/dL | MCV - MEAN CORPUSCULAR VOLUME: 86 fL | PLATELETS: 342 thou cells/ ul | WBC WHITE BLOOD CELLS: 916 K/uL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 5.3 % | HDL HIGH DENSITY LIPOPROTEIN: 43 mg/dL | LDL LOW DENSITY LIPOPROTEIN: 98 mg/dL | TGL TRIGLYCERIDE: 69 mg/dL | TOTAL CHOLESTEROL: 147 mg/dl | ALBUMIN (SERUM): 4.2 g/dL | ALKALINE PHOSPHOTASE: 66 IU/L | DIRECT BILIRUBIN: 0.2 mg/dl | SGOT (AST): 18 U/L | SGPT (ALT): 17 IU/L | TOTAL BILIRUBIN: 0.5 mg/dL | FIB4: 0.49 | FIB4: 0.49 | BICARBONATE: 22 meq/L | CHLORIDE: 105 meq/L | POTASSIUM: 4.1 meQ/L | SODIUM: 138 meq/L | TSH : 1.5 mIU/L | VITAMIN B12: 223 pg/mL | |
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
CAPSULE CHOLECALCIFEROL 2000 IU
D RISE
Medicine For VITAMIN D |
PO |
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
|
|
2 |
ROSUVASTATIN 20 MG
CRESTOR 20 MG |
|
0-0-1 |
AT BEDTIME
|
TILL NEXT VISIT |
| MAY CAUSE FATIGUE AND BODY PAIN | |
|
3 |
TABLET VENLAFAXINE PR 37.5 MG
VENTAB XL 37.5 MG |
PO |
1-0-0 |
BEFORE FOOD
|
TILL NEXT VIST |
|
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 17/Jun/2026 |
| Tests Suggested For Next Visit |
: |
| |
|
| |
|
|
